Page 5 - 《中国药房》2021年22期

CHINA PHARMACY

Volume 32，Number 22，November 30，2021

Semimonthly
Selected Table of Contents

Analysis of Risk Factors of MAH Pharmacovigilance Outsourcing …………………………………………………

………………………………………………… WU Qicong，LIU Ying，XU Yan，XIONG Huiyu，LIU Zuoren（2689）
Empirical Research on the Influential Factors of Chinese Crude Drug Price Based on SVAR Model ………………
………………………………………………………………………… JIANG Fengru，WEI Hua，TAO Qunshan（2695）
Determination of Aloesin in Rat Plasma by LC-MS/MS and Its Pharmacokinetic Study …………………………

…………………………… TAN Yinfeng，SUN Moxiao，ZHANG Lei，YANG Wenyue，LI Hailong，LI Youbin（2701）
Effects of Total Flavonoids from Chamomile on Lipid Metabolism of Hyperlipidemia Model Mice and Its
Mechanism …………………………………………………………………………………………… LAN Wei （2706）
Simultaneous Determination of 11 Active Components in Yuhuai Tablets by HPLC-QAMS ……………………

……………………………………………………………………… CHI Jing，BI Xia，LIU Zhimin，LIU Dejun（2713）
Determination of Plasma Protein Binding Rate of 3 Components from Glechoma longituba by UHPLC Combined
with Ultrafiltration ………… CHEN Weikang，LIU Dehong，XIONG Mingpeng，YUAN Hui，ZHOU Guoping（2720）
Establishment of HPLC Fingerprints，Content Determination and Chemical Pattern Recognition Analysis of Yuebi

Jiazhu Decoction ……………………………………… ZHAO Feng，GAO Taixiang，SHI Liyao，WANG Rui（2724）
Comparison of Chemical Constituents of Sinapis alba before and after Stir-frying Based on UPLC-MS and
Chemometrics Methods …………………………………………………………………… JIA Xiaozhou，YANG
Xiaolong，LU Xiaoying，LIANG Yueyi，HE Minyou，CHEN Xiangdong，WEI Mei，SUN Dongmei，LI Zhenyu（2731）

Study on Mechanism of the Improvement Effects of Xinmaikang on Atherosclerosis in Rabbits Based on TLR4/
NF-κB Signaling Pathway ………………………………… ZHOU Zhihui，CHEN He，WU Jinbo，YE Xiaohan（2736）
Content Determination of Multiple Indexes in Zhengxin Jiangzhi Tablets and Cluster Heatmap Analysis …………
CUI Xiaomin，JIN Yueti，REN Hui，HU Jing，DONG Mingzhi，HE Fang，LI Ning，QU Tong，CHEN Zhiyong（2743）

Study on the Effects of Tenuifolin on Brain Mitochondrial Autophagy in AD Model Mice Based on PINK1/Parkin
Signaling Pathway ……………………………………… LU Xiaohua，JIN Guifang，YU Hehan，YANG Hong（2748）
Establishment of HPLC Fingerprint and Content Determination of 5 Components in Papaveris Pericarpium ……
……………………… ZHANG Xiaoping，SHI Xiaofeng，ZHANG Hongyan，ZHU Renyuan，ZHANG Caixia（2755）

Cost-utility Analysis of Pembrolizumab in the Second-line Treatment of Advanced Hepatocellular Carcinoma
Based on Two Models …… MENG Rui，ZHOU Ting，SHI Fenghao，WANG Zijing，LUO Mengjie，MA Aixia（2761）
Determination of Pyrrotinib Concentration in Human Plasma by LC-MS/MS and Its Clinical Application ………

…………………………… ZHAO Zhenhuan，JING Weili，LIU Tao，LYU Zhiqiang，CAO Zhihong，XU Wen（2767）
Clinical Observation of Roxadustat in the Treatment of Chronic Kidney Disease Combined with Renal Anemia
…… TIAN Jingjing，ZHANG Shengyu，LIU Zhi，ZHANG Hua，ZHANG Xian，CHEN Xu，WANG Xiaojuan（2772）
Efficacy and Safety of Expectorant/antioxidants in the Treatment of COPD：Network Meta-analysis …………
……………………………………………………………… FU Yanxin，DAI Ang，DONG Liang，NING Kang（2778）

Analysis of Drug Use in a Lung Squamous Carcinoma Patient with Immune Checkpoint Inhibitors Associated
Adrenocortical Insufficiency …………………………………… WU Jun，LI Yan，WANG Yuanyuan，ZHU Xi（2785）